Fact CheckerSign in

NCT00963417Completed

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

TEXT-Bone: A Substudy of the TEXT Trial to Evaluate Serial Bone Markers for Bone Remodeling, Serial Growth Factors, and Bone Mineral Density

Source: ClinicalTrials.gov · Last updated 14 Jul 2025

Brief summary (registry, in English)

RATIONALE: Gathering information over time from bone density and laboratory tests of women with breast cancer treated with triptorelin and tamoxifen or exemestane may help the study of breast cancer in the future. PURPOSE: This clinical trial is studying changes in bone mineral density in women with breast cancer treated with triptorelin and tamoxifen or exemestane on protocol IBC SG-25-02 (TEXT).

Status (registry)
Completed
Study type
Interventional
Enrollment
119 (actual)
First submitted
20 Aug 2009
Start date
3 Aug 2009
Primary completion date
11 Mar 2011
Lead sponsor
ETOP IBCSG Partners Foundation
Diseases
Osteoporosis
NCT number
NCT00963417

What you commit to

  • Study type: Interventional
  • Participants enrolled: 119
  • From 3 Aug 2009 to the primary completion date, 11 Mar 2011
  • 13 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • DISEASE CHARACTERISTICS:
  • Patient must be eligible and enrolled in the TEXT-2 trial prior to enrolling in TEXT-Bone
  • Serial bone marrow density (BMD) measurements must be taken within the same institution
  • Hormone receptor positive
    • PATIENT CHARACTERISTICS:
  • See Disease Characteristics
  • Premenopausal
  • No bone fracture in the past 6 months that, in the investigator's judgement, could be related to bone fragility
  • No clinical or biochemical malabsorption syndrome, known vitamin D deficiency, active hyper- or hypoparathyroidism, or Paget's disease
  • No uncontrolled thyroid disease, Cushing disease, or other pituitary diseases
  • No other bone disease (including osteomalacia or osteogenesis imperfecta)
    • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • At least 6 months since prior and no concurrent bisphosphonate therapy (or other bone therapies such as PTH or strontium)
  • At least 6 months since prior glucocorticoid (\> 5 mg prednisone or equivalent) for \> 1 month
  • At least 12 months since prior anticonvulsants

Age in the registry: 18 years to 120 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (13)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Brisbane and Women's Hospital
Coordinator of this site? Confirm its status
BrisbaneAustraliaUnknown status
Peter MacCallum Cancer Center
Coordinator of this site? Confirm its status
East MelbourneAustraliaUnknown status
Maroondah Hospital
Coordinator of this site? Confirm its status
MelbourneAustraliaUnknown status
Box Hill Hospital
Coordinator of this site? Confirm its status
MelbourneAustraliaUnknown status
Royal Perth Hospital
Coordinator of this site? Confirm its status
PerthAustraliaUnknown status
Centre Hospitalier Regional de Huy
Coordinator of this site? Confirm its status
HuyBelgiumUnknown status
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumUnknown status
CHR Citadelle
Coordinator of this site? Confirm its status
LiègeBelgiumUnknown status
C.H.U. Sart-Tilman
Coordinator of this site? Confirm its status
LiègeBelgiumUnknown status
C.H.P.L.T. de Verviers
Coordinator of this site? Confirm its status
VerviersBelgiumUnknown status
Oncology Institute of Southern Switzerland
Coordinator of this site? Confirm its status
BellinzonaSwitzerlandUnknown status
Inselspital Bern
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status
Kantonsspital St. Gallen
Coordinator of this site? Confirm its status
Sankt GallenSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.